The whole NeuroImage journal editorial board resigned en bloc and founded a new journal, Imaging Neuroscience, in protest for Elsevier’s exploitative business model with high APCs.
I cannot quite understand the editorial boards of Neuron, Cell, Current Biology and other journals under Elsevier. Why would they want to remain associated with *that*?
Some of the editors are colleagues and acquaintances of mine or of some of us here–next time we meet, this question flies first.
If NeuroImage can do it, so can they. Exciting that the main argument was interest in the long term viability of the journal.
Also, when you say that there was a successful push for Open Access (OA) at Neuron, you mean its subscription, non-OA papers are accessible after 12 months?
Here https://www.cell.com/open-access it says that OA APC at Neuron are £7,270 / €8,120 / $9,080 and that there is an embargo period of 12 months for subscription articles.
@MatteoCarandini @albertcardona @bc_butler
I am on the editorial board of Current Biology. I know that the editor is aware of my personal preference of moving toward a non-profit model, since I have expressed it, but as far as I am aware, there has not been a collective effort to push the journal away from Elsevier. Maybe this will kickstart something. I would certainly be interested in participating, and at the very least, gaining a better understanding of the counterargument, if it exists.
Also, the board of current biology is not purely decorative - we frequently consult on manuscripts and help contribute/consider ideas for reviews, primers, etc.
<p>What is a Transformative Journal? A Transformative Journal (TJ) is a subscription/hybrid journal that is actively committed to transitioning to a fully Open Access journal. In addition, a Transformative Journal must: gradually increase the share of Open Access content; and offset subscription income from payments for publishing services (to avoid double payments). What problem is […]</p>
@MatteoCarandini @schoppik @tuthill @bc_butler
"Currante Biology" translates from Spanish to English as "Eager Beaver Biology" which has quite the ring to it.
Geoffrey North has done an excellent job, in my view, and for decades, at Current Biology. It's really a shame the journal is entangled with Elsevier. If he was to move it would be as if the journal had moved.
This is quite the graph, from your thread: annual profit at Elsevier in 2020 larger than annual HHMI grants and Wellcome Trust grants. So much research left on the table, swallowed up by RELX shareholders and Elsevier's fat cats' salaries and R&D to extend its tentacles beyond being a mere publisher. What a missed opportunity.
@elduvelle @MatteoCarandini @bc_butler
It's appalling really, to think that an entire funding agency the size of HHMI or Wellcome Trust is being wasted yearly on fees for ... wait for it ... requesting free labour from scientists and hosting PDF files online.
And that, not from the total costs but merely from just the profits (about 30%) of a single publisher, Elsevier. Then there are other publishers. Many multiples of HHMI and Wellcome Trust-level research funding are being poured into this nonsense, every year, like clockwork.
We don't believe in fairies, as the Journal of Machine Learning Research https://blogs.harvard.edu/pamphlet/2012/03/06/an-efficient-journal/ exemplifies. The status quo, as illustrated by Ken Anderson's post https://scholarlykitchen.sspnet.org/2011/09/01/uninformed-unhinged-and-unfair-the-monbiot-rant is entirely blind to the opportunity cost and has convinced itself that, well, everything is fine in #ScientificPublishing.
@albertcardona @elduvelle @MatteoCarandini @bc_butler
Agreed. I think we, as a field, might be able to put better resources in front of our members so as to support journals that keep fees to the minimum and are open access.
Right now there are a few "currents" flowing in the wrong direction.
First, many society journals charge publication fees, sometimes large. I have never been sure why they are what they are. Maybe it is just costs, but as was recently pointed out here, some societies profit from their journals, which doesn't seem in line with the point of societies...
Second, because almost all journals are charging publication fees, people are (probably) price insensitive, I suspect for most PIs, the difference between a $2000 and $3400 fee isn't something taken into account when deciding where to submit. Which helps the for-profit journals/publishers so long as they win on the "prestige" front.
Third, somewhat like the airline industry, for-profit publishers are always looking for ways to increase profits. Open-access, ironically, provided them a leverage point to charge larger (and sometimes crazy high) fees. Their excuse being lost revenue from open access. Which is probably mostly a fiction. I don't know how SFN justifies it, but their "article freely available as soon as it is published" fee is "a surcharge of $3,615" on top of the $1,710 member fee for publication ($2,360 for nonmembers). Wow. How do they come up with $3,615? And note that all articles will be publicly available 6 months after publication. So they are collecting $3,615 for 6 additional months of public access? Seems like a fee grab... (like charging to be able to pick your same economy seats early when buying a plane ticket...)
Things we might do:
1. If one is a member of a given society, it might be good to ask why the fees are what they are. And push to make them basically at cost.
2. Consider doing what the neuroimage board did. Along with MIT press, I think there are other on-line platforms that support low-cost journals (my university does so, I think at no cost: https://lps.library.cmu.edu/site/about/). If an editorial board from a respected journal moves en masse to a low-fee or free platform, I think the submissions move with it.
3. Would be nice to compile a list of publication fees at relevant journals and keep that on-line and accessible. Plus whether there is any profit built-in to the fees or not. If this were readily accessible, authors might consider it as a factor more often in their submission decisions. And shine some light on bad vs. good actors in this space. (There is this: https://doaj.org but the search isn't great in terms of disciplinary granularity).
4. More senior people need to acknowledge and respect publications in less well-known, but lower-fee journals to support movement to such. This means if evaluating people for hiring, promotion, etc. we need to look a the content of the papers, not the place where the paper appeared. Everyone says they do this, but in practice, people often don't. They heavily weigh prestige publications and discount less well-known publications. Maybe we should inversely weight publication "value" by the publication fees!
Unfortunately, for-profit, respected journals will continue to do okay because there are essentially an infinite pool of scientists who want their work to appear in peer-reviewed journals. But we can create a better eco-system for encouraging and supporting publication in open-access, lower-fee publishing.
@mtarr
⬆️ Really well-said with a lot of great ideas to improve the currently flawed scientific publication system!!
Too many PIs and hiring committees still rely on impact factor as one of their selection measures… when it is a completely flawed measure :(
@elduvelle @albertcardona @MatteoCarandini @bc_butler
My favorite. Faculty member in discussing job candidate CVs and discounting one of the candidate's publications: "That paper doesn't count, you have to PAY to publish there!" (they were out of touch and didn't realize someone from their lab had been paying publication fees for all their own papers....)
@Vitor @MatteoCarandini @bc_butler
Both the ERC and Wellcome Trust started their own open access journals—don’t know how it is going but I haven’t heard much about them.
NIH and HHMI mandated at various points to have papers as open access. Don’t know how well this is upheld.